Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease | Communications Medicine https://t.co/LZMzWPGyvO
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2023 – Sep 2023Where it's discussed
-
X / Twitter6 posts
-
YouTube1 videos
AI synopsis
What people are saying
The group emphasizes the innovative use of urinary extracellular vesicles as a non-invasive diagnostic tool, with comments referencing proteomics techniques and potential for early detection. Words like 'promising,' 'significant,' and phrases about new diagnostic opportunities show enthusiasm and recognition of the study's importance.
Most discussions acknowledge the study's findings as promising and significant for Parkinson's diagnosis, indicating moderate agreement.
Participants show high interest, likely due to the innovative non-invasive approach and potential clinical impact.
Comments include references to the methods (proteomics, biomarkers) and implications, suggesting thoughtful engagement.
The discussions highlight the potential for early detection and diagnostic advancements, implying a considerable impact in the field.
Abstract in brief
- This study focuses on discovering potential early diagnostic biomarkers for Parkinson's Disease (PD) by analyzing proteins and phosphoproteins in urinary extracellular vesicles (EVs) from different groups, including healthy individuals, those with genetic mutations linked to PD, and PD patients.
- Using advanced proteomics techniques like mass spectrometry, researchers identified thousands of unique proteins and phosphoproteins, finding several that are elevated in PD patients and involved in important disease-related pathways such as autophagy, neuroinflammation, and neuronal death.
- The study established a panel of candidate biomarkers, validated some through targeted testing methods, and demonstrated that analyzing EV contents in urine is a promising, non-invasive approach for early PD detection and potentially other diseases.]
Top posts
Most liked on X and BlueskyQuantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease https://t.co/NbAKhFWfGE
RT @InnovationFixer: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatur…
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease https://t.co/p4gBJQ9z4l
RT @NatRevNeurol: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures…
RT @InnovationFixer: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatur…
All mentions
Urinary Vesicle Proteomics for Parkinson's Disease Biomarkers
This study explores early diagnostic biomarkers for Parkinson's Disease by analyzing proteins in urinary extracellular vesicles, using advanced mass spectrometry to identify disease-related signatures for improved…
RT @InnovationFixer: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatur…
RT @InnovationFixer: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatur…
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease | Communications Medicine https://t.co/LZMzWPGyvO
RT @NatRevNeurol: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures…
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease https://t.co/NbAKhFWfGE
Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson's disease https://t.co/p4gBJQ9z4l